Measles-containing-vaccine second-dose (MCV2) immunization coverage in Eastern Mediterranean (WHO region)
Eastern Mediterranean (WHO region): Measles-containing-vaccine second-dose (MCV2) immunization coverage was 76.0% in 2025. ▲ Rising
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Eastern Mediterranean (WHO region), 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for measles-containing-vaccine second-dose (mcv2) immunization coverage in Eastern Mediterranean (WHO region) is 76.0%, measured in 2025. That is the highest value across all 26 years on record.
The figure is up 1.3% on the previous year and up 11.8% over ten years.
Over the whole period, measles-containing-vaccine second-dose (mcv2) immunization coverage in Eastern Mediterranean (WHO region) peaked at 76.0% in 2025 and was at its lowest, 27.0%, in 2000.
The long-run direction has been consistently rising across the 26 years of available data.
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Eastern Mediterranean (WHO region), year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 27.0% | — |
| 2001 | 33.0% | +22.2% |
| 2002 | 33.0% | +0.0% |
| 2003 | 32.0% | -3.0% |
| 2004 | 36.0% | +12.5% |
| 2005 | 39.0% | +8.3% |
| 2006 | 40.0% | +2.6% |
| 2007 | 40.0% | +0.0% |
| 2008 | 38.0% | -5.0% |
| 2009 | 50.0% | +31.6% |
| 2010 | 51.0% | +2.0% |
| 2011 | 54.0% | +5.9% |
| 2012 | 55.0% | +1.9% |
| 2013 | 59.0% | +7.3% |
| 2014 | 63.0% | +6.8% |
| 2015 | 68.0% | +7.9% |
| 2016 | 73.0% | +7.4% |
| 2017 | 73.0% | +0.0% |
| 2018 | 73.0% | +0.0% |
| 2019 | 75.0% | +2.7% |
| 2020 | 75.0% | +0.0% |
| 2021 | 75.0% | +0.0% |
| 2022 | 75.0% | +0.0% |
| 2023 | 73.0% | -2.7% |
| 2024 | 75.0% | +2.7% |
| 2025 | 76.0% | +1.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 36.8% | 27.0% | 50.0% | 10 |
| 2010s | 64.4% | 51.0% | 75.0% | 10 |
| 2020s | 74.8% | 73.0% | 76.0% | 6 |
More health data for Eastern Mediterranean (WHO region)
- Diphtheria - number of reported cases, gaps filled 5,830 (2025)
- Total tetanus - number of reported cases, gaps filled 524 (2025)
- Pertussis - number of reported cases, gaps filled 14,992 (2025)
- Measles - number of reported cases, gaps filled 83,590 (2025)
- Measles - number of reported cases, annual growth rate 6.13 % change on previous year (2025)
- Pertussis - number of reported cases, annual growth rate 140.84 % change on previous year (2025)
- Total tetanus - number of reported cases, annual growth rate 11.73 % change on previous year (2025)
- Total tetanus - number of reported cases 524 (2025)
- Pertussis - number of reported cases 14,992 (2025)
- Measles - number of reported cases 83,590 (2025)
Frequently asked questions
- What is measles-containing-vaccine second-dose (mcv2) immunization coverage in Eastern Mediterranean (WHO region)?
- Measles-containing-vaccine second-dose (mcv2) immunization coverage in Eastern Mediterranean (WHO region) was 76.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Eastern Mediterranean (WHO region)?
- The highest recorded value was 76.0% in 2025.
- What is the lowest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Eastern Mediterranean (WHO region)?
- The lowest recorded value was 27.0% in 2000.
- How does Eastern Mediterranean (WHO region) rank for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Eastern Mediterranean (WHO region) ranks 9th out of 11 groups with data for 2025.
- Is measles-containing-vaccine second-dose (mcv2) immunization coverage rising or falling in Eastern Mediterranean (WHO region)?
- Over the last ten years it is up 11.8%. The long-run trend across the full record is rising.
- Where does this Eastern Mediterranean (WHO region) data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).